Oppenheimer analyst Mohan Naidu lowered the price target on Evolent Health (NYSE: EVH) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Evolent Health (EVH) PT Lowered to $23 at JefferiesFebruary 27, 2019 2:04 PM Pre-Open Stock Movers 02/27: (TNDM) (VSM) (BBY) Higher; (WTW) (ELF) (HOLX) Lower (more...)February 27, 2019 9:19 AM Evolent Health (EVH) PT Lowered to $25 at CitiFebruary 27, 2019 7:33 AM Evolent Health (EVH) PT Lowered to $21.50 at Wells FargoFebruary 27, 2019 7:20 AM Evolent Health (EVH) PT Lowered to $20 at Cantor FitzgeraldFebruary 27, 2019 6:36 AM After-Hours Movers 02/26: (OPRX) (TNDM) (JAZZ) Higher; (WTW) (ELF) (TIVO) (more...)February 26, 2019 5:45 PM Evolent Health (EVH) Misses Q4 EPS by 3c, Offers GuidanceFebruary 26, 2019 4:19 PM Evolent Health Partners with Beacon Health Options and Empower Provider-Led Arkansas Shared Services Entity to Support Medicaid Operations in ArkansasFebruary 26, 2019 4:03 PM Evolent Health and River City Medical Group Establish a Management Services Organization for California Managed Care EntitiesFebruary 26, 2019 4:02 PM Evolent Health Announces Fourth Quarter and Full Year 2018 ResultsFebruary 26, 2019 4:01 PM Evolent Health (EVH) Sell-Off 'Overdone' - OppenheimerFebruary 25, 2019 9:28 AM